Kazakhstani scientists have developed an AI-based startup to determine immunity status

Medical startup ImmuniGuide, a resident of Astana Hub, has officially launched a unique artificial intelligence-based platform for assessing immune system status. This innovative product, developed by Kazakh scientists, has already been successfully implemented in an oncology clinic.

The main goal of the project is to provide free and accessible screening for the population. The platform analyzes a wide range of immunological data based on complete blood count results, detects hidden infections, and helps monitor the body's response to diseases, vaccinations, physical activity, and stress. Additionally, it provides recommendations for maintaining and strengthening immunity.

The key advantage of the project is the artificial intelligence underlying the system, which can process medical data with high speed and accuracy, providing detailed personalized reports in any language.

The Kazakh development demonstrates significant potential for improving healthcare and is ready for scaling to international markets. The project has already attracted interest from foreign countries. In particular, negotiations are underway with Malaysia for a pilot implementation of the platform in their territory. In the future, plans include scaling the technology and transferring it to other countries in Asia, Europe, and the United States.